Minhee Kang

机构：Harvard University, Jangan University, Cancer Research And Biostatistics · ORCID：0000-0003-0150-2419

发表论文 90 篇 · 总被引 1141 次 · h-index 19

代表论文

• HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse (2024 · JAMA · 被引 43)
• Incorporating estimands into clinical trial statistical analysis plans (2022 · Clinical Trials · 被引 42)
• Immunogenicity and Safety of Hepatitis B Virus (HBV) Vaccine With a Toll-Like Receptor 9 Agonist Adjuvant in HBV Vaccine-Naïve People With Human Immunodeficiency Virus (2023 · Clinical Infectious Diseases · 被引 36)
• Anogenital human papillomavirus virus DNA and sustained response to the quadrivalent HPV vaccine in women living with HIV-1 (2018 · Papillomavirus Research · 被引 16)
• Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings (2023 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 15)
• Early Progression and Immune Reconstitution Inflammatory Syndrome During Treatment of Mild-To-Moderate Kaposi Sarcoma in Sub-Saharan Africa and South America: Incidence, Long-Term Outcomes, and Effects of Early Chemotherapy (2020 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 被引 15)